Table 1.
Genes | Primers Sequences (5′–3′) |
---|---|
ANXA3 | forward: CATCTCATGGTGGCCCTAGTG |
reverse: CTGCTTTGCATCAAAGACTGCT | |
JNK | forward: CGTCTGGTGGAAGGAGAGAG |
reverse: TAATAACGGGGGTGGAGGAT | |
Caspase-3 | forward: CTCGGTCTGGTACAGATGTCGATG |
reverse: GGTTAACCCGGGTAAGAATGTGCA | |
α-SMA | forward: TCCGTAATGGGTCTGC |
reverse: ATGCTTGCTAGTCCAT | |
β-Tubulin | forward: GGCCAAGGGTCACTACACG |
reverse: GCAGTCGCAGTTTTCACACTC | |
OPN | forward: CTCCATTGACTCGAACGACTC |
reverse: CAGGTCTGCGAAACTTCTTAGAT | |
PCNA | forward: CCTGCTGGGATATTAGCTCCA |
reverse: CAGCGGTAGGTGTCGAAGC | |
Bcl-2 | forward: CTGTGCTGCTATCCTGC |
reverse: TGCAGCCACAATACTGT | |
Bax | forward: CCCGAGAGGTCTTTTTCCGAG |
reverse: CCAGCCCATGATGGTTCTGAT | |
MMP-9 | forward: TGTACCGCTATGGTTACACTCG |
reverse: GGCAGGGACAGTTGCTTCT | |
GAPDH | forward: AGAAGGCTGGGGCTCATTTG |
reverse: AGGGGCCATCCACAGTCTTC |
ANXA3, Annexin A3; α-SMA, α-smooth muscle actin; Bax, Bcl-2-associated X protein; Bcl-2, B cell leukemia/lymphoma 2; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; JNK, c-Jun N-terminal kinase; MMP-9, matrix metalloproteinase-9; OPN, osteopontin; PCNA, proliferating cell nuclear antigen.